Japan · Delayed Price · Currency is JPY Daiken Medical Statistics
Total Valuation
Daiken Medical has a market cap or net worth of JPY 12.09 billion. The enterprise value is 11.77 billion.
| Market Cap | 12.09B |
| Enterprise Value | 11.77B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Daiken Medical has 28.73 million shares outstanding.
| Current Share Class | 28.73M |
| Shares Outstanding | 28.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 49.93% |
| Owned by Institutions (%) | 4.39% |
| Float | 14.13M |
Valuation Ratios
The trailing PE ratio is 13.85.
| PE Ratio | 13.85 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | 50.39 |
| P/OCF Ratio | 21.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 49.05.
| EV / Earnings | 13.48 |
| EV / Sales | 1.15 |
| EV / EBITDA | 7.99 |
| EV / EBIT | 9.74 |
| EV / FCF | 49.05 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.54 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.43 |
| Debt / FCF | 8.80 |
| Interest Coverage | 85.31 |
Financial Efficiency
Return on equity (ROE) is 11.68% and return on invested capital (ROIC) is 12.34%.
| Return on Equity (ROE) | 11.68% |
| Return on Assets (ROA) | 6.87% |
| Return on Invested Capital (ROIC) | 12.34% |
| Return on Capital Employed (ROCE) | 14.37% |
| Weighted Average Cost of Capital (WACC) | 4.16% |
| Revenue Per Employee | 55.31M |
| Profits Per Employee | 4.72M |
| Employee Count | 185 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 3.91 |
Taxes
In the past 12 months, Daiken Medical has paid 301.44 million in taxes.
| Income Tax | 301.44M |
| Effective Tax Rate | 25.66% |
Stock Price Statistics
The stock price has decreased by -4.75% in the last 52 weeks. The beta is 0.10, so Daiken Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -4.75% |
| 50-Day Moving Average | 421.68 |
| 200-Day Moving Average | 445.18 |
| Relative Strength Index (RSI) | 44.62 |
| Average Volume (20 Days) | 27,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daiken Medical had revenue of JPY 10.23 billion and earned 873.49 million in profits. Earnings per share was 30.40.
| Revenue | 10.23B |
| Gross Profit | 3.86B |
| Operating Income | 1.21B |
| Pretax Income | 1.17B |
| Net Income | 873.49M |
| EBITDA | 1.47B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | 30.40 |
Balance Sheet
The company has 2.44 billion in cash and 2.11 billion in debt, with a net cash position of 323.00 million or 11.24 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 2.11B |
| Net Cash | 323.00M |
| Net Cash Per Share | 11.24 |
| Equity (Book Value) | 7.63B |
| Book Value Per Share | 265.49 |
| Working Capital | 4.10B |
Cash Flow
In the last 12 months, operating cash flow was 567.00 million and capital expenditures -327.00 million, giving a free cash flow of 240.00 million.
| Operating Cash Flow | 567.00M |
| Capital Expenditures | -327.00M |
| Depreciation & Amortization | 264.50M |
| Net Borrowing | 211.00M |
| Free Cash Flow | 240.00M |
| FCF Per Share | 8.35 |
Margins
Gross margin is 37.68%, with operating and profit margins of 11.82% and 8.54%.
| Gross Margin | 37.68% |
| Operating Margin | 11.82% |
| Pretax Margin | 11.48% |
| Profit Margin | 8.54% |
| EBITDA Margin | 14.40% |
| EBIT Margin | 11.82% |
| FCF Margin | 2.33% |
Dividends & Yields
This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 4.76%.
| Dividend Per Share | 20.00 |
| Dividend Yield | 4.76% |
| Dividend Growth (YoY) | -13.04% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 4.76% |
| Earnings Yield | 7.22% |
| FCF Yield | 1.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 13, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Nov 13, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Daiken Medical has an Altman Z-Score of 5.05 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.05 |
| Piotroski F-Score | 5 |